Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study

被引:6
作者
Marechaux, Sylvestre [1 ,2 ]
Rusinaru, Dan [3 ]
Jobic, Yannick [4 ]
Ederhy, Stephane [5 ]
Donal, Erwan [6 ,7 ]
Reant, Patricia [8 ,9 ]
Arnalsteen, Elise [10 ]
Boulanger, Jacques [11 ]
Garban, Thierry [12 ]
Ennezat, Pierre-Vladimir [13 ,14 ]
Jeu, Antoine [3 ]
Szymanski, Catherine [1 ,3 ]
Tribouilloy, Christophe [1 ,3 ]
机构
[1] Univ Picardie, INSERM U1088, Amiens, France
[2] Univ Catholique Lille, Univ Lille Nord France, GCS Grp Hosp, Inst Catholique Lille,Fac Med & Maieut, F-59000 Lille, France
[3] Ctr Hosp Univ Amiens, Pole Cardiovasc & Thorac, Amiens, France
[4] Hop Cavale Blanche, Dept Cardiol, F-29609 Brest, France
[5] Univ Paris 06, Hop St Antoine, Serv Cardiol, F-75012 Paris, France
[6] Ctr Hosp Univ Rennes, Hop Pontchaillou, Serv Cardiol & Malad Vasc, LTSI INSERM U642, Rennes, France
[7] Ctr Hosp Univ Rennes, Hop Pontchaillou, CIC IT 804, LTSI INSERM U642, Rennes, France
[8] Ctr Hosp Univ Bordeaux, Hop Cardiol Haut Leveque, CIC0005, F-33604 Pessac, France
[9] Univ Bordeaux 2, F-33000 Bordeaux, France
[10] Ctr Hosp Beauvais, Serv Med Interne & Cardiol, F-60021 Beauvais, France
[11] Ctr Hosp Compiegne, Serv Cardiol, F-60200 Compiegne, France
[12] Hop Univ G&R Laennec, Nantes, France
[13] Ctr Hosp Reg, F-59037 Lille, France
[14] Univ Lille, Hop Cardiol, F-59037 Lille, France
关键词
Valvular heart disease; Echocardiography; Drugs; NATIVE VALVE DISEASE; AORTIC REGURGITATION; ECHOCARDIOGRAPHY RECOMMENDATIONS; FENFLURAMINE-PHENTERMINE; MITRAL REGURGITATION; EUROPEAN ASSOCIATION; OBESE-PATIENTS; PREVALENCE; DEXFENFLURAMINE; THERAPY;
D O I
10.1093/ehjci/jeu212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The Food and Drug Administration (FDA) criteria for diagnosis of drug-induced valvular heart disease (DIVHD) are only based on the observation of aortic regurgitation >= mild and/or mitral regurgitation >= moderate. We sought to evaluate the diagnostic value of FDA criteria in a cohort of control patients and in a cohort of patients exposed to a drug (benfluorex) known to induce VHD. Methods and results This prospective, multicentre study included 376 diabetic control patients not exposed to valvulopathic drugs and 1000 subjects previously exposed to benfluorex. Diagnosis of mitral or aortic DIVHD was based on a combined functional and morphological echocardiographic analysis of cardiac valves. Patients were classified according to the FDA criteria [mitral or aortic-FDA(+) and mitral or aortic-FDA(-)]. Among the 376 control patients, 2 were wrongly classified as mitral-FDA(+) and 17 as aortic-FDA(+) (0.53 and 4.5% of false positives, respectively). Of those exposed to benfluorex, 48 of 58 with a diagnosis of mitral DIVHD (83%) were classified as mitral-FDA(-), and 901 of the 910 patients (99%) without a diagnosis of the mitral DIVHD group were classified as mitral-FDA(-). All 40 patients with a diagnosis of aortic DIVHD were classified as aortic-FDA(+), and 105 of the 910 patients without a diagnosis of aortic DIVHD (12%) were classified aortic-FDA(+). Older age and lower BMI were independent predictors of disagreement between FDA criteria and the diagnosis of DIVHD in patients exposed to benfluorex (both P <= 0.001). Conclusions FDA criteria solely based on the Doppler detection of cardiac valve regurgitation underestimate for the mitral valve and overestimate for the aortic valve the frequency of DIVHD. Therefore, the diagnosis of DIVHD must be based on a combined echocardiographic and Doppler morphological and functional analysis of cardiac valves.
引用
收藏
页码:158 / 165
页数:8
相关论文
共 29 条
[1]   Drug-induced fibrotic valvular heart disease [J].
Bhattacharyya, Sanjeev ;
Schapira, Anthony H. ;
Mikhailidis, Dimitri P. ;
Davar, Joseph .
LANCET, 2009, 374 (9689) :577-585
[2]   Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease [J].
Boudes, Audrey ;
Lavoute, Cecile ;
Avierinos, Jean-Francois ;
Le Dolley, Yvan ;
Villacampa, Chloe ;
Salem, Adrien ;
Loundou, Anderson Dieudonne ;
Michel, Nicolas ;
Renard, Sebastien ;
Habib, Gilbert .
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2011, 12 (09) :688-695
[3]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1061
[4]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[5]   Drug-induced valvular heart disease [J].
Cosyns, Bernard ;
Droogmans, Steven ;
Rosenhek, Raphael ;
Lancellotti, Patrizio .
HEART, 2013, 99 (01) :7-12
[6]   Echocardiographic Evidence for Valvular Toxicity of Benfluorex: A Double-Blind Randomised Trial in Patients with Type 2 Diabetes Mellitus [J].
Derumeaux, Genevieve ;
Ernande, Laura ;
Serusclat, Andre ;
Servan, Evelyne ;
Bruckert, Eric ;
Rousset, Hugues ;
Senn, Stephen ;
Van Gaal, Luc ;
Picandet, Brigitte ;
Gavini, Francois ;
Moulin, Philippe .
PLOS ONE, 2012, 7 (06)
[7]   Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease [J].
Droogmans, Steven ;
Cosyns, Bernard ;
D'haenen, Hugo ;
Creeten, Edwin ;
Weytjens, Caroline ;
Franken, Philippe R. ;
Scott, Benjamin ;
Schoors, Danny ;
Kemdem, Arsene ;
Close, Laurent ;
Vandenbossche, Jean-Luc ;
Bechet, Serge ;
Van Camp, Guy .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (09) :1442-1445
[8]   Role of echocardiography in toxic heart valvulopathy [J].
Droogmans, Steven ;
Kerkhove, Dirk ;
Cosyns, Bernard ;
Van Camp, Guy .
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2009, 10 (04) :467-476
[9]   Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study [J].
Frachon, Irene ;
Etienne, Yves ;
Jobic, Yannick ;
Le Gal, Gregoire ;
Humbert, Marc ;
Leroyer, Christophe .
PLOS ONE, 2010, 5 (04) :1-5
[10]   Spectrum of calcific aortic valve disease - Pathogenesis, disease progression, and treatment strategies [J].
Freeman, RV ;
Otto, CM .
CIRCULATION, 2005, 111 (24) :3316-3326